دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Cardiovascular Medicine at a Crossroads in the United Kingdom
Martin R. Cowie, MD, MSc John DeanfieldCBE, MD, PhD
doi : 10.1161/CIRCULATIONAHA.121.055387
Circulation. 2021;144:1457–1458
Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation
Joo Myung Lee, MD, MPH, PhD Ki Hong Choi, MD, PhD Jin-Oh Choi, MD, PhD Doosup Shin, MD Yoonjee Park, MD Juwon Kim, MD Seung Hun Lee, MD, PhD Darae Kim, MD, PhD Jeong Hoon Yang, MD, PhD Yang Hyun Cho, MD, PhD Kiick Sung, MD, PhD Ji Yeon Choi, RN Meesoon Park, RN Jung-Sun Kim, MD, PhD Taek Kyu Park, MD Young Bin Song, MD, PhD Joo-Yong Hahn, MD, PhD Seung-Hyuk Choi, MD, PhD Hyeon-Cheol Gwon, MD, PhD Jae K. Oh, MD, PhD Eun-Seok JeonMD, PhD
doi : 10.1161/CIRCULATIONAHA.121.056158
Circulation. 2021;144:1459–1472
Acute cellular rejection is a major determinant of mortality and retransplantation after heart transplantation. We sought to evaluate the prognostic implications of coronary microcirculatory dysfunction assessed by index of microcirculatory resistance (IMR) for the risk of acute cellular rejection after heart transplantation.
Can We Predict Rejection Early After Heart Transplantation?
William F. Fearon, MD Hannah A. ValantineMD
doi : 10.1161/CIRCULATIONAHA.121.056808
Circulation. 2021;144:1473–1475
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Ole Fröbert, MD Matthias Götberg, MD David Erlinge, MD Zubair Akhtar, MPH Evald H. Christiansen, MD Chandini R. MacIntyre, MBBS, PhD Keith G. Oldroyd, MBChB, MD Zuzana Motovska, MD Andrejs Erglis, MD Rasmus Moer, MD Ota Hlinomaz, MD Lars Jakobsen, MD Thomas Engstrøm, MD Lisette O. Jensen, MD Christian O. Fallesen, MD Svend E Jensen, MD Oskar Angerås, MD Fredrik Calais, MD Amra Kåregren, MD Jörg Lauermann, MD Arash Mokhtari, MD Johan Nilsson, MD Jonas Persson, MD Per Stalby, MD Abu K.M.M. Islam, MD Afzalur Rahman, MD Fazila Malik, MBBS Sohel Choudhury, PhD Timothy Collier, MSc Stuart J. Pocock, PhD John PernowMD
doi : 10.1161/CIRCULATIONAHA.121.057042
Circulation. 2021;144:1476–1484
Observational and small, randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease.
Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post–Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death
Erin D. Michos, MD, MHS Jacob A. UdellMD, MPH
doi : 10.1161/CIRCULATIONAHA.121.057534
Circulation. 2021;144:1485–1488
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)
Justin A. Ezekowitz, MBBCh, MSc Yinggan Zheng, MA, MEd Alain Cohen-Solal, MD, PhD Vojt?ch Melenovský, MD, PhD Jorge Escobedo, MD, MSc Javed Butler, MD, MPH, MBA Adrian F. Hernandez, MD, MHS Carolyn S.P. Lam, MBBS, PhD Christopher M. O’Connor, MD Burkert Pieske, MD Piotr Ponikowski, MD, PhD Adriaan A. Voors, MD, PhD Christopher deFilippi, MD Cynthia M. Westerhout, PhD Ciaran McMullan, MBBCh, MMSc Lothar Roessig, MD Paul W. Armstrong, MD for the VICTORIA Study Group
doi : 10.1161/CIRCULATIONAHA.121.056797
Circulation. 2021;144:1489–1499
In the VICTORIA trial (Vericiguat Global Study in Patients with Heart Failure with Reduced Ejection Fraction), anemia occurred more often in patients treated with vericiguat (7.6%) than with placebo (5.7%). We explored the association between vericiguat, randomization hemoglobin, development of anemia, and whether the benefit of vericiguat related to baseline hemoglobin.
Integrated Stress Response Couples Mitochondrial Protein Translation With Oxidative Stress Control
Guangyu Zhang, MD, PhD Xiaoding Wang, MD, PhD Chao Li, PhD Qinfeng Li, MD, PhD Yu A. An, PhD Xiang Luo, MD, PhD Yingfeng Deng, PhD Thomas G. Gillette, PhD Philipp E. Scherer, PhD Zhao V. WangPhD
doi : 10.1161/CIRCULATIONAHA.120.053125
Circulation. 2021;144:1500–1515
The integrated stress response (ISR) is an evolutionarily conserved process to cope with intracellular and extracellular disturbances. Myocardial infarction is a leading cause of death worldwide. Coronary artery reperfusion, the most effective means to mitigate cardiac damage of myocardial infarction, causes additional reperfusion injury. This study aimed to investigate the role of the ISR in myocardial ischemia/reperfusion (I/R).
From the Literature
Tracy Hampton
doi : 10.1161/CIRCULATIONAHA.121.057645
Circulation. 2021;144:1516–1517
Grouped Beating After Acute Inferior Myocardial Infarction
Yao-Tsung Chuang, MD Kwo-Chang Ueng, MD, PhD Chin-Feng TsaiMD, PhD
doi : 10.1161/CIRCULATIONAHA.121.056366
Circulation. 2021;144:1518–1520
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
John R. Power, MD Joachim Alexandre, MD, PhD Arrush Choudhary, MD Benay Ozbay, MD Salim Hayek, MD, PhD Aarti Asnani, MD Yuichi Tamura, MD, PhD Mandar Aras, MD, PhD Jennifer Cautela, MD Franck Thuny, MD, PhD Lauren Gilstrap, MD Dimitri Arangalage, MD, PhD Steven Ewer, MD Shi Huang, PhD Anita Deswal, MD, MPH Nicolas L. Palaskas, MD Daniel Finke, MD Lorenz Lehmann, MD Stephane Ederhy, MD Javid Moslehi, MD Joe-Elie Salem, MD, PhD
doi : 10.1161/CIRCULATIONAHA.121.055816
Circulation. 2021;144:1521–1523
American Heart Association’s 2024 Impact Goal: Every Person Deserves the Opportunity for a Full, Healthy Life
Donald M. Lloyd-Jones, MD, ScM Mitchell Elkind, MD, MS Michelle A. AlbertMD, MPH
doi : 10.1161/CIRCULATIONAHA.121.057617
Circulation. 2021;144:e277–e279
Letter by Romani et al Regarding Article, “Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation”
Federico Romani, MD Michelle M. Monasky, PhD Carlo PapponeMD, PhD
doi : 10.1161/CIRCULATIONAHA.121.055364
Circulation. 2021;144:e280–e281
Response by Leor et al to Letter Regarding Article, “Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation”
Jonathan Leor, MD Eilon Ram, MD Nili Naftali-Shani, PhD Olga Shaihov-TeperMSc
doi : 10.1161/CIRCULATIONAHA.121.056313
Circulation. 2021;144:e282
